Meda AB
Trading name | OTCPK:MDABY |
---|---|
Headquarters | Solna, Sweden |
Revenue | >kr 15,000,000,000 (2014) |
Number of employees | 5,202 (2014) |
Website | www.meda.se/ |
Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are sold in more than 150 countries.[1]
Meda was listed on the Stockholm stock market until it was acquired by Mylan in 2016 through a cash and stock offer.
Mergers, acquisitions and divestments
In 2014, Meda acquired the Italian firm RottaPharm Madaus in order to add consumer health products to their portfolio.[2] Meda explored in 2015 the possibility of divesting its United States division, Meda Pharmaceuticals, to raise funds for expansion in other areas.[2].mw-parser-output table.clade{border-spacing:0;margin:0;font-size:100%;line-height:100%;border-collapse:separate;width:auto}.mw-parser-output table.clade table.clade{width:100%}.mw-parser-output table.clade td{border:0;padding:0;vertical-align:middle;text-align:center}.mw-parser-output table.clade td.clade-label{width:0.8em;border:0;padding:0 0.2em;vertical-align:bottom;text-align:center}.mw-parser-output table.clade td.clade-slabel{border:0;padding:0 0.2em;vertical-align:top;text-align:center}.mw-parser-output table.clade td.clade-bar{vertical-align:middle;text-align:left;padding:0 0.5em}.mw-parser-output table.clade td.clade-leaf{border:0;padding:0;text-align:left;vertical-align:middle}.mw-parser-output table.clade td.clade-leafR{border:0;padding:0;text-align:right}
Meda |
| |||||||||
|
References
^ "About Meda". Meda AB. Retrieved 15 August 2015..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}
[self-published source]
^ ab Ewing, Adam; Baigorri, Manuel (27 August 2015). "Swedish Drugmaker Meda Said to Weigh Sale of U.S. Operations". Bloomberg Business. Retrieved 28 August 2015.